Apotex Corp. today announced the launch of nilotinib capsules, a generic version of Tasigna®, in the United States, with 180 days of ...

Oral antidiabetic drugs play an important role in the management of type 2 diabetes and were developed to regulate blood glucose levels in individuals who are resistant to the effects of insulin or ...

The HHS said it has taken the first step toward implementing most-favored-nation pricing for prescription drugs.

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has ...

The Trump administration's escalating calls for drug companies to lower prices underscore just how stuck the industry is in ...

Axsome Therapeutics, Inc. (Axsome), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it has entered into a settlement ...

The global branded generics market is forecasted to expand from USD 382.4 billion in 2025 to USD 860.5 billion by 2035, registering a CAGR of 8.4%. This growth is driven by rising healthcare ...

We sat down with Nithin Stephen, Director of Commercial Development specializing in Drug Product at Resilience ... to today’s ...

Weight loss drugs like Wegovy and Zepbound are getting cheaper, if you are willing to pay out of pocket for the medications.

Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders ...

Aurobindo Pharma Limited reported a slight dip in its consolidated net profit for the fourth quarter ended March 31,25, despite a 10.6 per cent up in revenue.

MannKind's pipeline and technology outweigh competitive risks and support future upside. See why we recommend a buy rating on ...